Safety and efficacy of DLL3 CAR-T cells armored with dnTGFBR2 in a subject with recurrent small-cell lung cancer: case report - Quiz - MDSpire

Safety and efficacy of DLL3 CAR-T cells armored with dnTGFBR2 in a subject with recurrent small-cell lung cancer: case report

  • By

  • Chelsey M. Williams

  • Susanne M. Arnold

  • John L. Villano

  • Erika N. Amarilla Alonso

  • Christine F. Brainson

  • Paul O. Schwarzenberger

  • Sahista Vahora

  • Ayman Qasrawi

  • Reinhold Munker

  • B. Mark Evers

  • Zhonglin Hao

  • July 7, 2026

  • 0 min

Share

Original Source(s)

Safety and efficacy of DLL3 CAR-T cells armored with dnTGFBR2 in a subject with recurrent small-cell lung cancer: case report

  • by Chelsey M. Williams, Susanne M. Arnold, John L. Villano, Erika N. Amarilla Alonso, Christine F. Brainson, Paul O. Schwarzenberger, Sahista Vahora, Ayman Qasrawi, Reinhold Munker, B. Mark Evers, Zhonglin Hao

  • July 7, 2026

Related Content

Feasibility evaluation of tumor treating fields for brainstem gliomas

Cytokine delivery and targeting strategies in pet dogs with cancer: a comparative immuno-oncology approach

Assessment of growth and pain trajectories for children and adolescents receiving chemotherapy for acute lymphoblastic leukemia in Northern Thailand using group-based trajectory modeling